| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
St Rose Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. St Rose Hospital is based in Hayward, CA. You can find more information on St Rose Hospital at www.strosehospital.org
RXVP Inc is a Chester, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The mission of the Society is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy. Learn more at www.sts.org.
Buckeye Pharmaceuticals is a Beachwood, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.